Short answer · Medically reviewed summary · Last updated: 2026-04-06
Alagille syndrome is primarily caused by genetic mutations in the JAG1 gene or, less frequently, the NOTCH2 gene, which disrupt the Notch signaling pathway essential for proper organ development. The Genetic Basis of Alagille Syndrome The Notch signaling pathway acts like a complex communication network between cells, instructing them on how to differentiate and form structures during embryonic development. In Alagille syndrome, a mutation in the JAG1 gene (found in approximately 90-95% of cases) or the NOTCH2 gene prevents this cellular "messaging system" from functioning correctly.
2 people with Alagille Syndrome have shared their first-person experience on this question at DiseaseMaps.
Alagille syndrome is primarily caused by genetic mutations in the JAG1 gene or, less frequently, the NOTCH2 gene, which disrupt the Notch signaling pathway essential for proper organ development.
The Notch signaling pathway acts like a complex communication network between cells, instructing them on how to differentiate and form structures during embryonic development. In Alagille syndrome, a mutation in the JAG1 gene (found in approximately 90-95% of cases) or the NOTCH2 gene prevents this cellular "messaging system" from functioning correctly. When these signals fail, the body does not properly develop the bile ducts in the liver, the structure of the heart, or certain facial features, which are hallmarks of Alagille syndrome.
Most cases of Alagille syndrome are inherited in an autosomal dominant pattern, meaning a child only needs to inherit one copy of the mutated gene from one parent to manifest the condition. However, approximately 30-50% of cases are described as "de novo," occurring spontaneously in the individual without a family history. It is important to distinguish that Alagille syndrome is a genetic disorder; there are no known environmental triggers, infectious agents, or lifestyle factors that cause the disease. It is not caused by anything a parent did or did not do during pregnancy.
While we have a strong understanding of the primary genetic drivers of Alagille syndrome, researchers are currently investigating why the severity of the disease varies so significantly, even among family members with the exact same mutation. This phenomenon, known as variable expressivity, suggests that other "modifier genes" or epigenetic factors may influence how the disease manifests. Ongoing clinical research focuses on better understanding these secondary genetic influences to improve diagnostic accuracy and develop targeted therapies that might one day modulate the Notch signaling pathway to treat the systemic effects of Alagille syndrome.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.